Form 8-K - Current report:
SEC Accession No. 0001437749-24-031300
Filing Date
2024-10-16
Accepted
2024-10-16 08:00:12
Documents
16
Period of Report
2024-10-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K crvo20241015_8k.htm   iXBRL 8-K 29353
2 EXHIBIT 99.1 ex_732854.htm EX-99.1 16633
7 logosmlr.jpg GRAPHIC 3845
  Complete submission text file 0001437749-24-031300.txt   188872

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA crvo-20241015.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20241015_def.xml EX-101.DEF 11425
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20241015_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20241015_pre.xml EX-101.PRE 11585
18 EXTRACTED XBRL INSTANCE DOCUMENT crvo20241015_8k_htm.xml XML 2820
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 241373309
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)